Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Viruses
|
July 30, 2025
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
Alessia Siribelli, Sara Diotallevi, Laura Galli, et al.
The Journal of Infectious Diseases
|
September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV
Mehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
The Journal of Antimicrobial Chemotherapy
|
November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting
Rebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents
|
June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting
Tommaso Clemente, Laura Galli, Andrea Poli, et al.
The Journal of Infection
|
March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infection
Tommaso Clemente, Roberta Caccia, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2024
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry
Maria Mazzitelli, Domenico Pontillo, Tommaso Clemente, et al.
AIDS (London, England)
|
November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIV
Tommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
HIV Medicine
|
April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era
Tommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
July 4, 2024
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Camilla Muccini, Nicola Gianotti, Sara Diotallevi, et al.
Open Forum Infectious Diseases
|
May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort
Alessandra Vergori, Adriana Cervo, Ashley Roen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Viruses
|
July 30, 2025
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
Alessia Siribelli, Sara Diotallevi, Laura Galli, et al.
The Journal of Infectious Diseases
|
September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV
Mehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
The Journal of Antimicrobial Chemotherapy
|
November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting
Rebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents
|
June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting
Tommaso Clemente, Laura Galli, Andrea Poli, et al.
The Journal of Infection
|
March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infection
Tommaso Clemente, Roberta Caccia, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2024
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry
Maria Mazzitelli, Domenico Pontillo, Tommaso Clemente, et al.
AIDS (London, England)
|
November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIV
Tommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
HIV Medicine
|
April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era
Tommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
July 4, 2024
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Camilla Muccini, Nicola Gianotti, Sara Diotallevi, et al.
Open Forum Infectious Diseases
|
May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort
Alessandra Vergori, Adriana Cervo, Ashley Roen, et al.
Page
of 4